PATH vs TFX · P/E 19, rev $1.61B vs P/E 2083, rev $3.05B
Uipath Inc (PATH) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported TFX revenue for 2024-12-31 was $3.05B. Net income was $69.7M. Revenue was up 2.4% from 2023-12-31 to 2024-12-31. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the PATH and TFX stock pages for the full models.
Not investment advice.